Hezkue
Phase 2Small molecule
Hezkue is one of 58 small molecule programs targeting Absorption. It is currently in Phase 2.
3
Indications
3
Total Trials
3
Active Trials
57
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
53 competitors in Erectile Dysfunction
#DrugCompanyPhaseTrials
1Cialis
Eli LillyApproved
Levitra
BayerApproved
Viagra
VViatris Specialty LLC
Approved
Rifadin
SanofiApproved
Flomax
SanofiApproved
Avandia
Jazz PharmaceuticalsApproved
Norvir
AbbVieApproved
Avelox
BayerApproved
Cipro
BayerApproved
Caverject
VViatris Specialty LLC
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Alcohol Consumption1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Hezkue. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- AAspargo Labs, Inc